Study Name: Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
19 locations found
- Investigational Site Number 8965
Location: Cullman, Alabama 35058
- Investigational Site Number 8946
Location: Phoenix, Arizona 85060
- Investigational Site Number 8954
Location: Phoenix, Arizona 85013
- Investigational Site Number 8962
Location: Fort Collins, Colorado 80528
- Investigational Site Number 8920
Location: Maitland, Florida 32761
- Investigational Site Number 8953
Location: St. Petersburg, Florida 33701
- Investigational Site Number 8914
Location: Ft. Wayne, Indiana 63104
- Investigational Site Number 8940
Location: Indianapolis, Indiana 46256
- Investigational Site Number 8922
Location: Shreveport, Louisiana 71103
- Investigational Site Number 8955
Location: Grand Rapids, Michigan 49503
- Investigational Site Number 8949
Location: Traverse City, Michigan 49684
- Investigational Site Number 8937
Location: St Louis, Missouri 63104
- Investigational Site Number 8951
Location: Albuquerque, New Mexico 87131
- Investigational Site Number 8925
Location: New York, New York 10029
- Investigational Site Number 8941
Location: Charlotte, North Carolina 28204
- Investigational Site Number 8924
Location: Dayton, Ohio 45409
- Investigational Site Number 8905
Location: Round Rock, Tennessee 78681
- Investigational Site Number 8930
Location: Burlington, Vermont 05401
- Investigational Site Number 8963
Location: Seattle, Washington 98122
|